2021年11月9日简报:日本15个月来,首次无单日新增新冠死亡病例;新加坡要求拒绝接种新冠疫苗者染病后自付医药费;泰国重开国门满7天超2万人入境,其中发现15例新冠确诊病例;新冠后遗症需要引起关注

2021-11-09 MedSci整理 MedSci整理

截至北京时间2021年11月9日8时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5097万例,新增339,548例,达到250,978,9

截至北京时间2021年11月9日8时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过2亿5097万例,新增339,548例,达到250,978,967例。累计死亡病例506.9万例,达到5,069,737例。新增死亡为4,775例。康复为227,213,307例,重症和危重症病人达到76,357例;全球新冠确诊病例超过100万例的国家达36个,111个国家病例超10万例。昨日报道:2021年11月8日简报:国内今冬明春仍坚持病毒零容忍政策;明年新冠或变为地方性流行病;国内新冠小分子口服药也取得不错进展

丹麦新冠病毒感染率上升 政府高度关注疫情发展

当地时间11月8日,丹麦广播电视台(DR)报道,随着丹麦最近几周新冠病毒感染率显著上升,住院患者数也在增加。丹麦首相弗雷泽里克森表示“政府正在高度关注疫情的发展,这种疾病再次对我们的社会产生严重影响”,并建议民众尽快接种新冠疫苗。

丹麦卫生和药品管理局局长提出重新引入新冠疫苗通行证。丹麦卫生大臣要求流行病委员会评估新冠肺炎是否可以再次归为危害社会疾病,这将意味着流行病法可以再次启用,政府可以再次推出限制措施。

当地时间8日,丹麦新增新冠肺炎确诊病例2294例,累计确诊404855例;新增死亡病例2例,累计死亡2740例;目前有303名患者在医院接受治疗。

泰国重开国门满7天超2万人入境 其中发现15例新冠确诊病例

泰国政府新冠肺炎疫情管理中心当地时间8日通报,自11月1日泰国重新打开国门恢复接待国际游客以来,1日至6日共有20092名国际旅客入境。入境旅客主要来自美国、德国、英国、日本、韩国、俄罗斯等国家。1日至6日经入境病毒检测发现15例新冠肺炎确诊病例,占比约0.07%。

此外,来自泰国外交部的数据显示,截至11月6日,有超过9万人通过Thailand Pass系统申请入境泰国,已有约3.4万人获得批准。获得入境通行证仅仅是进入泰国的第一步,此后还须办理签证,提供新冠疫苗接种证明、72小时内的新冠病毒阴性检测证明、包含新冠肺炎治疗的健康保险、24小时隔离酒店预订单等文件。

入境后旅客须到预订酒店隔离24小时并接受一次新冠病毒检测,结果为阴性就可以离开酒店自由活动。如果入境人员因各种原因未接种新冠疫苗,则须到酒店接受7至10天的防疫隔离

喝凉茶还能预防新冠?香雪制药被罚30万元

11月7日,香雪制药发布公告,称其孙公司广东香雪医药有限公司(以下简称“香雪医药”)于 2021年11月4 日收到广州市黄埔区市场监督管理局下发的《行政处罚决定书》,根据行政处罚决定书2020年2月26日至2月28日香雪医药在网站和微信公众号香雪制药发布疫情居家预防广州市卫健委推荐广州疫情中医药防控专家组联开等内容对粤抗1号瓶装凉茶饮料进行宣传在今年2月至3月香雪医药生产了1883箱粤抗1号瓶装凉茶饮料在瓶身标签和纸箱上标有上述内容广州市黄埔区市场监督管理局认为香雪医药上述行为违反了相关广告法责令其停止发布广告并罚款30万元主动调整生产计划更改下架相关广告及时召回未流入市场流通领域的产品对相关责任人员进行了处罚本次行政处罚对公司生产经营不会造成重大影响对经营业绩不会产生重大不利影响对存续期的公司债不产生影响

新冠后遗症需要引起关注

很多疾病都有后遗症,新型冠状病毒也一样可以对我们的身体造成很长时间的影响。虽然,随着时间延长,症状会逐步消失。只是影响可能是多方面的,并不单纯是肺部的问题,最为常见的,包括经常感觉疲倦,有的时候呼吸急促,感觉胸部疼痛。而且在一些患者中也可以看到嗅觉失灵,味觉失灵,四肢无力。

毫无疑问,这些症状都会给我们的生活带来影响,英国牛津大学曾经做过调查研究,发现27万感染新冠的市民虽然痊愈了,但仍有37%的患者至少出现了一种新冠后遗症。

而且如果感染过程中属于重症,那么在之后出现新冠后遗症的可能性更大。

11月7日全国新增新冠89例 11省份本土65例 

11月7日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例89例。其中境外输入病例24例(上海6例,云南6例,山西3例,广东3例,内蒙古1例,浙江1例,福建1例,山东1例,广西1例,四川1例),含3例由无症状感染者转为确诊病例(浙江1例,广东1例,四川1例);本土病例65例(辽宁20例,均在大连市;河南18例,其中郑州市16例、周口市2例;河北8例,均在辛集市;黑龙江6例,均在黑河市;四川4例,均在成都市;云南3例,均在德宏傣族景颇族自治州;甘肃2例,均在兰州市;北京1例,在昌平区;内蒙古1例,在锡林郭勒盟;江西1例,在上饶市;重庆1例,在长寿区),含18例由无症状感染者转为确诊病例(河南14例,辽宁2例,四川2例)。无新增死亡病例。无新增疑似病例。

据卫健委官网消息,当日新增治愈出院病例56例,解除医学观察的密切接触者1620人,重症病例较前一日减少4例。

境外输入现有确诊病例388例(其中重症病例3例),现有疑似病例1例。累计确诊病例9760例,累计治愈出院病例9372例,无死亡病例。

截至11月7日24时,据31个省(自治区、直辖市)和新疆生产建设兵团报告,现有确诊病例1202例(其中重症病例28例),累计治愈出院病例91985例,累计死亡病例4636例,累计报告确诊病例97823例,现有疑似病例1例。累计追踪到密切接触者1281004人,尚在医学观察的密切接触者49691人。

31个省(自治区、直辖市)和新疆生产建设兵团报告新增无症状感染者46例,其中境外输入12例,本土34例(辽宁12例,均在大连市;河南7例,均在郑州市;江西6例,均在上饶市;云南3例,均在德宏傣族景颇族自治州;甘肃3例,均在兰州市;四川2例,均在成都市;河北1例,在石家庄市);当日转为确诊病例21例(境外输入3例);当日解除医学观察11例(均为境外输入);尚在医学观察的无症状感染者456例(境外输入335例)。

累计收到港澳台地区通报确诊病例28887例。其中,香港特别行政区12368例(出院12036例,死亡213例),澳门特别行政区77例(出院75例),台湾地区16442例(出院13742例,死亡847例)。

韩政府购40.4万人份新冠口服药,将于明年2月起分批接收

韩国疾病管理厅发言人于当地时间11月8日表示,韩国政府决定预购40.4万人份的新冠口服药,计划明年2月起分批接收。这是政府首次公布新冠口服药的具体进口时间。

据韩联社8日报道,韩国疾病管理厅发言人高载英当日表示,韩国决定预购40.4万人份的新冠口服药,计划明年2月起分批接收。高载英称,要综合考量新增确诊病例数量和食品医药品安全处的使用许可,讨论是否需要额外采购。韩国中央灾难安全对策本部第一次长、保健福祉部长官权德哲此前曾表示,希望2022年1到2月拿到订购药品。

报道称,为尽量减少分阶段防疫转型过程中出现的新冠重症病例数量,政府其间一直在争取预购40.4万人份新冠口服药。9月,韩政府同美国默沙东(MSD)公司签署20万人份的采购协议。10月,同辉瑞公司签署7万人份的采购协议。除此之外,还有13.5万人份的采购事宜正在与默沙东、辉瑞和瑞士罗氏三家公司洽商当中,预计11月签约。

日本15个月来 首次无单日新增新冠死亡病例

日本政府发布的新冠疫情最新数据显示,日本7日没有报告新增新冠死亡病例,为15个多月来首次降至零。

据厚生劳动省统计,日本7日报告单日新增新冠确诊病例162例;重症患者数与前一天相同,仍是100人;单日新增死亡病例则是自2020年8月2日以来首次为零。

日本单日新增新冠死亡病例5月中旬处于峰值,达到200人以上,近来随着疫情好转,逐步降至个位数。

日本迄今累计新冠确诊病例172万多例,累计死亡1.8万多例。现阶段,日本新冠疫苗全程接种率约为73%。

日本近来疫情大幅好转,从8月中下旬单日新增确诊病例超2.5万例到9月底以来快速下降到日增一两千例,进入10月以后逐渐下降到三位数。10月1日起,日本解除在全国多个地区实施的紧急状态。

新加坡要求拒绝接种新冠疫苗者染病后自付医药费

当地时间11月8日,新加坡卫生部宣布,12月8日起,符合接种新冠疫苗要求却坚持不接种的公众感染新冠病毒后,须自行支付医药费用。

目前,新加坡政府为所有新加坡公民、永久居民和长期证件持有者支付新冠肺炎医药费,从国外返回新加坡不久后确诊的患者除外。但新加坡政府会继续承担不适合接种疫苗者的医药费。已接种疫苗的公众若感染病毒,新加坡政府也会继续承担其医药费,直到疫情更为稳定。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1683301, encodeId=af8f1683301c5, content=<a href='/topic/show?id=8cc8353823f' target=_blank style='color:#2F92EE;'>#医药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35382, encryptionId=8cc8353823f, topicName=医药费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=702327951438, createdName=pcw115, createdTime=Fri Aug 19 22:43:20 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772139, encodeId=fab51e721398b, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Wed May 11 17:43:20 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294645, encodeId=408912946457c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410183, encodeId=0f7414101831e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418811, encodeId=7efe1418811e5, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446251, encodeId=941f1446251fb, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068403, encodeId=f4161068403a2, content=已阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/560f15a0277d43b6a97093df9d0bd9c6/495b8d7c43964f24a256a019fb92ab8e.jpg, createdBy=4aac5114077, createdName=1461fe16m02, createdTime=Tue Nov 09 08:54:22 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-08-19 pcw115
  2. [GetPortalCommentsPageByObjectIdResponse(id=1683301, encodeId=af8f1683301c5, content=<a href='/topic/show?id=8cc8353823f' target=_blank style='color:#2F92EE;'>#医药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35382, encryptionId=8cc8353823f, topicName=医药费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=702327951438, createdName=pcw115, createdTime=Fri Aug 19 22:43:20 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772139, encodeId=fab51e721398b, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Wed May 11 17:43:20 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294645, encodeId=408912946457c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410183, encodeId=0f7414101831e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418811, encodeId=7efe1418811e5, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446251, encodeId=941f1446251fb, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068403, encodeId=f4161068403a2, content=已阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/560f15a0277d43b6a97093df9d0bd9c6/495b8d7c43964f24a256a019fb92ab8e.jpg, createdBy=4aac5114077, createdName=1461fe16m02, createdTime=Tue Nov 09 08:54:22 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1683301, encodeId=af8f1683301c5, content=<a href='/topic/show?id=8cc8353823f' target=_blank style='color:#2F92EE;'>#医药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35382, encryptionId=8cc8353823f, topicName=医药费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=702327951438, createdName=pcw115, createdTime=Fri Aug 19 22:43:20 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772139, encodeId=fab51e721398b, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Wed May 11 17:43:20 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294645, encodeId=408912946457c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410183, encodeId=0f7414101831e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418811, encodeId=7efe1418811e5, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446251, encodeId=941f1446251fb, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068403, encodeId=f4161068403a2, content=已阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/560f15a0277d43b6a97093df9d0bd9c6/495b8d7c43964f24a256a019fb92ab8e.jpg, createdBy=4aac5114077, createdName=1461fe16m02, createdTime=Tue Nov 09 08:54:22 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1683301, encodeId=af8f1683301c5, content=<a href='/topic/show?id=8cc8353823f' target=_blank style='color:#2F92EE;'>#医药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35382, encryptionId=8cc8353823f, topicName=医药费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=702327951438, createdName=pcw115, createdTime=Fri Aug 19 22:43:20 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772139, encodeId=fab51e721398b, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Wed May 11 17:43:20 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294645, encodeId=408912946457c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410183, encodeId=0f7414101831e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418811, encodeId=7efe1418811e5, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446251, encodeId=941f1446251fb, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068403, encodeId=f4161068403a2, content=已阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/560f15a0277d43b6a97093df9d0bd9c6/495b8d7c43964f24a256a019fb92ab8e.jpg, createdBy=4aac5114077, createdName=1461fe16m02, createdTime=Tue Nov 09 08:54:22 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-10 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1683301, encodeId=af8f1683301c5, content=<a href='/topic/show?id=8cc8353823f' target=_blank style='color:#2F92EE;'>#医药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35382, encryptionId=8cc8353823f, topicName=医药费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=702327951438, createdName=pcw115, createdTime=Fri Aug 19 22:43:20 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772139, encodeId=fab51e721398b, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Wed May 11 17:43:20 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294645, encodeId=408912946457c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410183, encodeId=0f7414101831e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418811, encodeId=7efe1418811e5, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446251, encodeId=941f1446251fb, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068403, encodeId=f4161068403a2, content=已阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/560f15a0277d43b6a97093df9d0bd9c6/495b8d7c43964f24a256a019fb92ab8e.jpg, createdBy=4aac5114077, createdName=1461fe16m02, createdTime=Tue Nov 09 08:54:22 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-10 huirong
  6. [GetPortalCommentsPageByObjectIdResponse(id=1683301, encodeId=af8f1683301c5, content=<a href='/topic/show?id=8cc8353823f' target=_blank style='color:#2F92EE;'>#医药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35382, encryptionId=8cc8353823f, topicName=医药费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=702327951438, createdName=pcw115, createdTime=Fri Aug 19 22:43:20 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772139, encodeId=fab51e721398b, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Wed May 11 17:43:20 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294645, encodeId=408912946457c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410183, encodeId=0f7414101831e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418811, encodeId=7efe1418811e5, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446251, encodeId=941f1446251fb, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068403, encodeId=f4161068403a2, content=已阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/560f15a0277d43b6a97093df9d0bd9c6/495b8d7c43964f24a256a019fb92ab8e.jpg, createdBy=4aac5114077, createdName=1461fe16m02, createdTime=Tue Nov 09 08:54:22 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-10 bshuang
  7. [GetPortalCommentsPageByObjectIdResponse(id=1683301, encodeId=af8f1683301c5, content=<a href='/topic/show?id=8cc8353823f' target=_blank style='color:#2F92EE;'>#医药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35382, encryptionId=8cc8353823f, topicName=医药费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=702327951438, createdName=pcw115, createdTime=Fri Aug 19 22:43:20 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772139, encodeId=fab51e721398b, content=<a href='/topic/show?id=122b63381b3' target=_blank style='color:#2F92EE;'>#死亡病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63381, encryptionId=122b63381b3, topicName=死亡病例)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59d938370790, createdName=xuqianhua, createdTime=Wed May 11 17:43:20 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1294645, encodeId=408912946457c, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59218, encryptionId=ca6e592189b, topicName=日本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f634250, createdName=chentianping, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410183, encodeId=0f7414101831e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418811, encodeId=7efe1418811e5, content=<a href='/topic/show?id=da8839121bb' target=_blank style='color:#2F92EE;'>#后遗症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39121, encryptionId=da8839121bb, topicName=后遗症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b3422729, createdName=huirong, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446251, encodeId=941f1446251fb, content=<a href='/topic/show?id=f8cb8e958ae' target=_blank style='color:#2F92EE;'>#药费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87958, encryptionId=f8cb8e958ae, topicName=药费)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=0Yy1x0ia6yKWyKUaG6Ja0UA&s=100&t=1564295847, createdBy=646f5195679, createdName=bshuang, createdTime=Wed Nov 10 22:43:20 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068403, encodeId=f4161068403a2, content=已阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/560f15a0277d43b6a97093df9d0bd9c6/495b8d7c43964f24a256a019fb92ab8e.jpg, createdBy=4aac5114077, createdName=1461fe16m02, createdTime=Tue Nov 09 08:54:22 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 1461fe16m02

    已阅读

    0

相关资讯

柳叶刀:新冠突破性感染死亡与哪些特征和风险相关?

接种者发生新冠突破性感染的个体他们的新冠相关死亡风险随着合并症(即同时存在其他疾病)数量的增加而增加,有五种合并症的人发生新冠相关死亡的风险显著高于没有合并症的人,男性高于女性,大多数年龄超过75岁。

2021年11月3日简报:欧洲再次成为疫情震中;全球因新冠死亡人数持续下降;美国推迟批准青少年使用莫德纳疫苗;日本欲放宽入境限制

截至北京时间2021年11月3日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4820万例,新增332,231例,达到248,203,6

2021年11月8日简报:国内今冬明春仍坚持病毒零容忍政策;明年新冠或变为地方性流行病;国内新冠小分子口服药也取得不错进展

截至北京时间2021年11月7日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿5025万例,新增412,535例,达到250,250,7

2021年11月4日简报:阿联酋疫苗接种高达97%,疫情得到完全控制;此次国内疫情波及十多个省份

截至北京时间2021年11月4日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4820万例,新增332,231例,达到248,203,6

2021年11月2日简报:张文宏全新发声,个人配合防疫十分重要;全球正在逐步放开出境游限制;全球重症人数降至低点后,再次上升

截至北京时间2021年11月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4780万例,新增324,207例,达到247,805,4

2021年11月6日简报:辉瑞新冠口服药物Paxlovid降低住院或死亡率89%!有望终结新冠;中国内地31省份新冠疫苗接种超23亿剂次;

截至北京时间2021年11月6日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过2亿4980万例,新增481,298例,达到249,801,6